- Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial2018 | 1. lékařská fakulta
- Prevalence of Walking-Related Motor Fatigue in Persons With Multiple Sclerosis: Decline in Walking Distance Induced by the 6-Minute Walk Test2016 | 3. lékařská fakulta
- Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial2016 | 1. lékařská fakulta
- Which walking capacity tests to use in multiple sclerosis? A RIMS multicenter study providing the basis for a core set2012 | 3. lékařská fakulta
- Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial2016 | 1. lékařská fakulta
- Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension study2022 | 1. lékařská fakulta
- Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension2013 | 1. lékařská fakulta
- Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies)2020 | 1. lékařská fakulta
- Total hip arthroplasty in patients with Parkinson´s disease2013 | Lékařská fakulta v Hradci Králové
- Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study2019 | 1. lékařská fakulta
- Chronic thromboembolic pulmonary hypertension: role of medical therapy2013 | 1. lékařská fakulta
- Atrial fibrillation and atrial tachycardia in patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy2020 | 1. lékařská fakulta
- Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial2019 | Publikace bez příslušnosti k fakultě
- Residual pulmonary hypertension after pulmonary endarterectomy: A meta-analysis2018 | 1. lékařská fakulta, Fakulta tělesné výchovy a sportu
- Long-term experience with implantable treprostinil pumps in pulmonary arterial hypertension2020 | 1. lékařská fakulta
- Indirect treatment comparison and cost-minimization analysis of riociguat versus selexipag in patients with pulmonary arterial hypertension2022 | 1. lékařská fakulta, Fakulta sociálních věd
- Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2)2015 | 1. lékařská fakulta
- Identifying potential parameters associated with response to switching from a PDE5i to riociguat in RESPITE2020 | 1. lékařská fakulta
- Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis. A Randomized Clinical Trial2018 | 1. lékařská fakulta
- RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors2017 | 1. lékařská fakulta
- Determinants of CAT (COPD Assessment Test) scores in a population of patients with COPD in central and Eastern Europe: The POPE study2019 | Lékařská fakulta v Hradci Králové
- Path integration in large-scale space and with novel geometries: Comparing vector addition and encoding-error models2020 | 1. lékařská fakulta
- The impact of riociguat on clinical parameters and quality of life in patients with chronic thromboembolic pulmonary hypertension - results of a retrospective clinical registry2021 | 1. lékařská fakulta
- Vztah ventilačních plicních parametrů, tolerance fyzické zátěže a kvality života u pacientů s chronickou obstrukční plicní nemocí2002 | Lékařská fakulta v Hradci Králové, 2. lékařská fakulta
- Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension2017 | 1. lékařská fakulta
- Effect of a 6-month pedometer-based walking intervention on functional capacity in patients with chronic heart failure with reduced (HFrEF) and with preserved (HFpEF) ejection fraction: study protocol for two multicenter randomized controlled trials2017 | 1. lékařská fakulta, Lékařská fakulta v Hradci Králové, Fakulta tělesné výchovy a sportu
- Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: Results from an international prospective registry2011 | 1. lékařská fakulta
- Long-term results from the EARLY study of bosentan in WHO functional class II pulmonary arterial hypertension patients2014 | 1. lékařská fakulta
- Plicní arteriální hypertenze u cystické fibrózy: studie u dospělých kandidátů transplantace plic2014 | 2. lékařská fakulta
- Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study2017 | Publikace bez příslušnosti k fakultě
